Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 83-88

  Paulsen, T ^a,b   Kaern J ^b   Trope C ^b,c  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

FIGO stage I; Ovarian neoplasm; Population based; Surgery; Survival

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; ASCITES; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLEAR CELL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OMENTECTOMY; OVARY CANCER; PERIOPERATIVE COMPLICATION; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RUPTURE; SALPINGOOOPHORECTOMY; TUMOR RUPTURE;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; NORWAY; OVARIAN NEOPLASMS; PLOIDIES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79957702442     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.038     Document Type: Article

References (25)

1. Paulsen T, Kaern J, Kjaerheim K, Trope C, Tretli S. Symptoms and referral of women with epithelial ovarian tumors. Int J Gynaecol Obstet 2005;88(1):31-7. (Pubitemid 40023091)
2. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357(9251):176-82. (Pubitemid 32108089)
3. Sjövall K, Nilsson B, Einhorn N. Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer 1994;4(5):333-6.
4. Lécuru F, Desfeux P, Camatte S, Bissery A, Robin F, Blanc B, et al. Stage I ovarian cancer: comparison of laparoscopy and laparotomy on staging and survival. Eur J Gynaecol Oncol 2004;25(5):571-6. (Pubitemid 39287114)
5. Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet 2008;101(2):205-10.
6. Sevelda P, Dittrich C, Salzer H. Prognostic value of the rupture of the capsule in stage I epithelial ovarian carcinoma. Gynecol Oncol 1989;35(3):321-2. (Pubitemid 20025894)
7. Ahmed FY, Wiltshaw E, A'Hern RP, Nicol B, Shepherd J, Blake P, et al. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996;14(11):2968-75. (Pubitemid 26371455)
8. Bakkum-Gamez JN, Richardson DL, Seamon LG, Aletti GD, Powless CA, Keeney GL, et al. Influence of intraoperative capsule rupture on outcomes in stage I epithelial ovarian cancer. Obstet Gynecol 2009;113(1):11-7.
9. Goudge CS, Li Z, Downs Jr LS. The influence of intraoperative tumor rupture on recurrence risk in Stage Ic epithelial ovarian cancer. Eur J Gynaecol Oncol 2009;30(1):25-8.
10. Zubrod CG, Schneidermann M, Frei E, Bridley C, Gold GL, Shnider B, et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
11. Kildal W, Kaern J, Kraggerud SM, Abeler VM, Sudbø J, Tropè CG, Lothe RA, Danielsen HE. Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors-relation to clinicopathologic variables. Cancer Genet Cytogenet 2004 Nov;155(1):25-32. (Pubitemid 39446609)
12. Gjertsen F. Cause of death registry-an important data source for medical research. Tidsskr Nor Laegeforen 2002;122(26):2551-4. (Pubitemid 35291360)
13. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer 2008;112(10):2202-10. (Pubitemid 351628630)
14. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K. Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75(2):263-73. (Pubitemid 20062245)
15. Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F, et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol 2004;35(8):961-70. (Pubitemid 39037179)
16. Canis M, Botchorishvili R, Manhes H, Wattiez A, Mage G, Pouly JL, et al. Management of adnexal masses: role and risk of laparoscopy. Semin Surg Oncol 2000;19(1):28-35. (Pubitemid 30439312)
17. Ødegaard E, Staff AC, Langebrekke A, Engh V, Onsrud M. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstet Gynecol Scand 2007;86(5):620-6.
18. Kolomainen DF, A'Hern R, Coxon FY, Fisher C, King DM, Blake PR, et al. Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy? J Clin Oncol 2003;21(16):3113-8.
19. Timmers PJ, Zwinderman AH, Teodorovic I, Vergote I, Trimbos JB. Clear cell carcinoma compared with serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial. Int J Gynecol Cancer 2009;19(1):88-93.
20. Tropé C, Kaern J, Hogberg T, Abeler V, Hagen B, Kristensen G, Onsrud M, Pettersen E, Rosenberg P, Sandvei R, Sundfor K, Vergote I. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol 2000 Mar;11(3):281-8. (Pubitemid 30214664)
21. Tropé C, Kaern J. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J Clin Oncol 2007 Jul 10;25(20):2909-20. (Pubitemid 47123155)
22. Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A, Gynecologic Cancer InterGroup. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer. Int J Gynecol Cancer 2010 Aug;20(6):945-52.
23. Trimbos B, Timmers P, Pecorelli S, Coens C, Ven K, van der Burg M, Casado A. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst 2010 Jul 7;102(13):982-7.
24. Ben-Arie A, Lavie O. Cyst rupture during surgery. Lancet 2001 Jul 7;358(9275):72-72 author reply 73.
25. Verleye L, Ottevanger PB, van der GW, Reed NS, Vergote I. EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 2009;45(4):517-26.